Education
About Us
Working with TipRanks
Follow Us
Champions Oncology Inc (CSBR)
NASDAQ:CSBR
Total Valuation
Champions Oncology has a market cap or net worth of $92.72M. The enterprise value is $94.88M.
Market Cap$92.72M
Enterprise Value$94.88M
Share Statistics
Champions Oncology has 13,777,170 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,777,170
Owned by Insiders14.25%
Owned by Institutions33.19%
Financial Efficiency
Champions Oncology’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 24.19%.
Return on Equity (ROE)0.00
Return on Assets (ROA)0.25
Return on Invested Capital (ROIC)24.19%
Return on Capital Employed (ROCE)0.24
Revenue Per Employee0.00
Profits Per Employee22.39K
Employee Count210
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Champions Oncology is 20.7. Champions Oncology’s PEG ratio is ―.
PE Ratio20.7
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow-66.75
PEG Ratio―
Income Statement
In the last 12 months, Champions Oncology had revenue of 0.00 and earned 4.70M in profits. Earnings per share was 0.34.
Revenue0.00
Gross Profit-28.39M
Operating Income4.55M
Pretax Income4.63M
Net Income4.70M
EBITDA4.55M
Earnings Per Share (EPS)0.34
Cash Flow
In the last 12 months, operating cash flow was -9.38M and capital expenditures -115.00K, giving a free cash flow of -9.50M billion.
Operating Cash Flow-9.38M
Free Cash Flow-9.50M
Free Cash Flow per Share-0.69
Dividends & Yields
Champions Oncology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.29
52-Week Price Change57.89%
50-Day Moving Average7.34
200-Day Moving Average7.73
Relative Strength Index (RSI)44.79
Average Volume (3m)36.86K
Important Dates
Champions Oncology upcoming earnings date is Sep 10, 2025, After Close (Confirmed).
Last Earnings DateJul 23, 2025
Next Earnings DateSep 10, 2025
Ex-Dividend Date―
Financial Position
Champions Oncology as a current ratio of 0.00, with Debt / Equity ratio of 120.15%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Champions Oncology has paid -75.00K in taxes.
Income Tax-75.00K
Effective Tax Rate-0.02
Enterprise Valuation
Champions Oncology EV to EBITDA ratio is 21.45, with an EV/FCF ratio of 13.96.
EV to Sales0.00
EV to EBITDA21.45
EV to Free Cash Flow13.96
EV to Operating Cash Flow13.22
Balance Sheet
Champions Oncology has $3.20M in cash and marketable securities with $6.44M in debt, giving a net cash position of $3.23M billion.
Cash & Marketable Securities$3.20M
Total Debt$6.44M
Net Cash$3.23M
Net Cash Per Share$0.23
Tangible Book Value Per Share$1.40
Margins
Gross margin is 37.13%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin37.13%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Champions Oncology is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$12.00
Price Target Upside81.82% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast13.54%
EPS Growth Forecast―